Skip to main content
Top
Published in: Journal of Neurology 4/2019

Open Access 01-04-2019 | Tremor | Original Communication

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT

Authors: Elina Mäkinen, Juho Joutsa, Elina Jaakkola, Tommi Noponen, Jarkko Johansson, Miia Pitkonen, Reeta Levo, Tuomas Mertsalmi, Filip Scheperjans, Valtteri Kaasinen

Published in: Journal of Neurology | Issue 4/2019

Login to get access

Abstract

Introduction

Total parkinsonian motor symptom severity correlates with presynaptic striatal dopamine function in patients with Parkinson’s disease. There is a lack of studies that have investigated the associations between parkinsonian motor signs and striatal dopaminergic deficiency in patients with parkinsonism of an unknown origin. Identification of specific motor signs associated with the highest likelihood of striatal dopamine deficiency could aid the differential diagnostics of parkinsonian and tremor syndromes.

Methods

In this cross-sectional clinical and imaging study, detailed motor examinations were performed for 221 patients with parkinsonism or tremor of an unknown origin immediately before dopamine transporter (DAT) [I-123]FP-CIT SPECT imaging. Region-of-interest and voxel-based methods were used to investigate striatal DAT deficiency in relation to individual motor signs.

Results

Upper extremity rigidity and facial expression were the only motor signs that differentiated patients with normal and abnormal striatal DAT function. The presence of any upper extremity rigidity showed the highest likelihood of DAT deficiency (OR 4.79, 95% CI 1.56–14.75, P = 0.006) followed by reduced facial expression (OR 2.14, 95% CI 1.14–4.00, P = 0.018). In patients with DAT deficits, reduced facial expression was associated with DAT deficiency specifically in the caudate nucleus, and increased upper extremity rigidity was associated with DAT loss in the dorsal putamen (FWE-corrected P < 0.05).

Conclusions

Increased upper extremity muscle tone and hypomimia are independently associated with a higher likelihood of striatal hypodopaminergic imaging finding. This information can be used as a factor when the clinical need of auxiliary investigations, such as DAT SPECT, is considered for patients with parkinsonism.
Appendix
Available only for authorised users
Literature
1.
go back to reference Marsden CD, Donaldson I, Schneider S, Bhatia KD (2012) Marsden’s book of movement disorders. Oxford University Press, Oxford Marsden CD, Donaldson I, Schneider S, Bhatia KD (2012) Marsden’s book of movement disorders. Oxford University Press, Oxford
2.
go back to reference Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (2016) Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86:566–576CrossRefPubMed Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (2016) Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86:566–576CrossRefPubMed
3.
go back to reference Kaasinen V, Vahlberg T (2017) Striatal dopamine in Parkinson disease: a meta-analysis of imaging studies. Ann Neurol 82:873–882CrossRef Kaasinen V, Vahlberg T (2017) Striatal dopamine in Parkinson disease: a meta-analysis of imaging studies. Ann Neurol 82:873–882CrossRef
4.
go back to reference Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P (2011) The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain 134:3146–3166CrossRef Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P (2011) The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain 134:3146–3166CrossRef
5.
go back to reference Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, Någren K, Nobili F, Walker Z, Van Laere K (2010) EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging 37:443–450CrossRef Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, Någren K, Nobili F, Walker Z, Van Laere K (2010) EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging 37:443–450CrossRef
6.
go back to reference Ba F, Martin WR (2015) Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice. Parkinsonism Relat Disord 21:87–94CrossRefPubMed Ba F, Martin WR (2015) Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice. Parkinsonism Relat Disord 21:87–94CrossRefPubMed
7.
go back to reference Pirker W (2003) Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Mov Disord 18(Suppl 7):S43–S51CrossRef Pirker W (2003) Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Mov Disord 18(Suppl 7):S43–S51CrossRef
8.
go back to reference Helmich RC, Hallett M, Deuschl G, Toni I, Bloem BR (2012) Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain 135:3206–3226CrossRefPubMedPubMedCentral Helmich RC, Hallett M, Deuschl G, Toni I, Bloem BR (2012) Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain 135:3206–3226CrossRefPubMedPubMedCentral
9.
go back to reference Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Force MD (2008) S.U.R.T. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170CrossRefPubMed Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Force MD (2008) S.U.R.T. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170CrossRefPubMed
10.
go back to reference Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442CrossRef Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442CrossRef
11.
go back to reference Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L, Disease, M.D.S.T.F.o.R.S.f.P.s (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020–1028CrossRefPubMed Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L, Disease, M.D.S.T.F.o.R.S.f.P.s (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020–1028CrossRefPubMed
12.
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
13.
go back to reference Albert NL, Unterrainer M, Diemling M, Xiong G, Bartenstein P, Koch W, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu L, Kluge A, Ziebell M, Darcourt J, Nobili F, Pagani M, Sabri O, Hesse S, Borght TV, Van Laere K, Tatsch K, la Fougère C (2016) Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes. Eur J Nucl Med Mol Imaging 43:1315–1322CrossRefPubMed Albert NL, Unterrainer M, Diemling M, Xiong G, Bartenstein P, Koch W, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu L, Kluge A, Ziebell M, Darcourt J, Nobili F, Pagani M, Sabri O, Hesse S, Borght TV, Van Laere K, Tatsch K, la Fougère C (2016) Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes. Eur J Nucl Med Mol Imaging 43:1315–1322CrossRefPubMed
14.
go back to reference Mäkinen E, Joutsa J, Johansson J, Mäki M, Seppänen M, Kaasinen V (2016) Visual versus automated analysis of [I-123]FP-CIT SPECT scans in parkinsonism. J Neural Transm (Vienna) 123:1309–1318CrossRef Mäkinen E, Joutsa J, Johansson J, Mäki M, Seppänen M, Kaasinen V (2016) Visual versus automated analysis of [I-123]FP-CIT SPECT scans in parkinsonism. J Neural Transm (Vienna) 123:1309–1318CrossRef
15.
16.
go back to reference Jaakkola E, Joutsa J, Kaasinen V (2016) Predictors of normal and abnormal outcome in clinical brain dopamine transporter imaging. J Neural Transm (Vienna) 123:205–209CrossRef Jaakkola E, Joutsa J, Kaasinen V (2016) Predictors of normal and abnormal outcome in clinical brain dopamine transporter imaging. J Neural Transm (Vienna) 123:205–209CrossRef
17.
go back to reference Bologna M, Fabbrini G, Marsili L, Defazio G, Thompson PD, Berardelli A (2013) Facial bradykinesia. J Neurol Neurosurg Psychiatry 84:681–685CrossRefPubMed Bologna M, Fabbrini G, Marsili L, Defazio G, Thompson PD, Berardelli A (2013) Facial bradykinesia. J Neurol Neurosurg Psychiatry 84:681–685CrossRefPubMed
18.
go back to reference Agostino R, Bologna M, Dinapoli L, Gregori B, Fabbrini G, Accornero N, Berardelli A (2008) Voluntary, spontaneous, and reflex blinking in Parkinson’s disease. Mov Disord 23:669–675CrossRefPubMed Agostino R, Bologna M, Dinapoli L, Gregori B, Fabbrini G, Accornero N, Berardelli A (2008) Voluntary, spontaneous, and reflex blinking in Parkinson’s disease. Mov Disord 23:669–675CrossRefPubMed
19.
go back to reference Ricciardi L, Bologna M, Morgante F, Ricciardi D, Morabito B, Volpe D, Martino D, Tessitore A, Pomponi M, Bentivoglio AR, Bernabei R, Fasano A (2015) Reduced facial expressiveness in Parkinson’s disease: a pure motor disorder? J Neurol Sci 358:125–130CrossRefPubMed Ricciardi L, Bologna M, Morgante F, Ricciardi D, Morabito B, Volpe D, Martino D, Tessitore A, Pomponi M, Bentivoglio AR, Bernabei R, Fasano A (2015) Reduced facial expressiveness in Parkinson’s disease: a pure motor disorder? J Neurol Sci 358:125–130CrossRefPubMed
20.
go back to reference Ricciardi L, Visco-Comandini F, Erro R, Morgante F, Bologna M, Fasano A, Ricciardi D, Edwards MJ, Kilner J (2017) Facial emotion recognition and expression in Parkinson’s disease: an emotional mirror mechanism? PLoS One 12:e0169110CrossRefPubMedPubMedCentral Ricciardi L, Visco-Comandini F, Erro R, Morgante F, Bologna M, Fasano A, Ricciardi D, Edwards MJ, Kilner J (2017) Facial emotion recognition and expression in Parkinson’s disease: an emotional mirror mechanism? PLoS One 12:e0169110CrossRefPubMedPubMedCentral
21.
go back to reference Santangelo G, Vitale C, Picillo M, Cuoco S, Moccia M, Pezzella D, Erro R, Longo K, Vicidomini C, Pellecchia MT, Amboni M, Brunetti A, Salvatore M, Barone P, Pappatà S (2015) Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson’s disease patients. Parkinsonism Relat Disord 21:489–493CrossRef Santangelo G, Vitale C, Picillo M, Cuoco S, Moccia M, Pezzella D, Erro R, Longo K, Vicidomini C, Pellecchia MT, Amboni M, Brunetti A, Salvatore M, Barone P, Pappatà S (2015) Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson’s disease patients. Parkinsonism Relat Disord 21:489–493CrossRef
22.
go back to reference Enrici I, Adenzato M, Ardito RB, Mitkova A, Cavallo M, Zibetti M, Lopiano L, Castelli L (2015) Emotion processing in Parkinson’s disease: a three-level study on recognition, representation, and regulation. PLoS One 10:e0131470CrossRefPubMedPubMedCentral Enrici I, Adenzato M, Ardito RB, Mitkova A, Cavallo M, Zibetti M, Lopiano L, Castelli L (2015) Emotion processing in Parkinson’s disease: a three-level study on recognition, representation, and regulation. PLoS One 10:e0131470CrossRefPubMedPubMedCentral
23.
go back to reference Espay AJ, Beaton DE, Morgante F, Gunraj CA, Lang AE, Chen R (2009) Impairments of speed and amplitude of movement in Parkinson’s disease: a pilot study. Mov Disord 24:1001–1008CrossRefPubMed Espay AJ, Beaton DE, Morgante F, Gunraj CA, Lang AE, Chen R (2009) Impairments of speed and amplitude of movement in Parkinson’s disease: a pilot study. Mov Disord 24:1001–1008CrossRefPubMed
24.
go back to reference Berardelli A, Rothwell JC, Thompson PD, Hallett M (2001) Pathophysiology of bradykinesia in Parkinson’s disease. Brain 124:2131–2146CrossRefPubMed Berardelli A, Rothwell JC, Thompson PD, Hallett M (2001) Pathophysiology of bradykinesia in Parkinson’s disease. Brain 124:2131–2146CrossRefPubMed
25.
go back to reference Schilder JC, Overmars SS, Marinus J, van Hilten JJ, Koehler PJ (2017) The terminology of akinesia, bradykinesia and hypokinesia: Past, present and future. Parkinsonism Relat Disord 37:27–35CrossRefPubMed Schilder JC, Overmars SS, Marinus J, van Hilten JJ, Koehler PJ (2017) The terminology of akinesia, bradykinesia and hypokinesia: Past, present and future. Parkinsonism Relat Disord 37:27–35CrossRefPubMed
26.
go back to reference Bajaj NP, Gontu V, Birchall J, Patterson J, Grosset DG, Lees AJ (2010) Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. J Neurol Neurosurg Psychiatry 81:1223–1228CrossRefPubMed Bajaj NP, Gontu V, Birchall J, Patterson J, Grosset DG, Lees AJ (2010) Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. J Neurol Neurosurg Psychiatry 81:1223–1228CrossRefPubMed
27.
go back to reference Nicastro N, Garibotto V, Badoud S, Burkhard PR (2016) Scan without evidence of dopaminergic deficit: a 10-year retrospective study. Parkinsonism Relat Disord 31:53–58CrossRefPubMed Nicastro N, Garibotto V, Badoud S, Burkhard PR (2016) Scan without evidence of dopaminergic deficit: a 10-year retrospective study. Parkinsonism Relat Disord 31:53–58CrossRefPubMed
28.
go back to reference Kaasinen V, Kinos M, Joutsa J, Seppänen M, Noponen T (2014) Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s disease. Eur J Nucl Med Mol Imaging 41:1931–1937CrossRefPubMed Kaasinen V, Kinos M, Joutsa J, Seppänen M, Noponen T (2014) Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s disease. Eur J Nucl Med Mol Imaging 41:1931–1937CrossRefPubMed
Metadata
Title
Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
Authors
Elina Mäkinen
Juho Joutsa
Elina Jaakkola
Tommi Noponen
Jarkko Johansson
Miia Pitkonen
Reeta Levo
Tuomas Mertsalmi
Filip Scheperjans
Valtteri Kaasinen
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 4/2019
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09202-6

Other articles of this Issue 4/2019

Journal of Neurology 4/2019 Go to the issue